Functional interactions between calmodulin and estrogen receptor-α

Slides:



Advertisements
Similar presentations
John A. Barrett Ph.D. Ziopharm Oncology, Boston MA 02129
Advertisements

ROLE OF INTRACELLULAR CALCIUM IN GLUCOCORTICOID-EVOKED LYMPHOID CELL APOPTOSIS Devin Morris California State University, Northridge.
Cystic Fibrosis Pathogens Activate Ca 2+ -dependent mitogen-activated Protein Kinase Signaling Pathways in Airway Epithelial Cells by Aubrey Osborne and.
CHAPTER 9 LECTURE SLIDES
Plasma membrane Nuclear membranes Hormone receptor Adenylate cyclase ATP Active Protein Kinase A PO 4 G cAMP Inctive Protein Kinase A PO 4 Active pKA enters.
Signal Transduction Pathways
Lecture 10: Cell Communication II. GPCR signaling is inactivated by arrestins.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Cell Communication III. G-protein linked receptor.
Advanced Cancer Topics Journal Review 4/16/2009 AD.
Chapter 12: The Cell Cycle
Biosignaling Cells - receive and act on signals Signal brings about response Types of signals: Autocrine - acting on same cell that produces them Paracrine.
Speaker:Chung-Han Wang. introduction Obesity being one of the major issues of public health nowadays, with more than 500 million obese adults worldwide.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
GENE REGULATION ch 18 CH18 Bicoid is a protein that is involved in determining the formation of the head and thorax of Drosophila.
Applying An Understanding of the Mechanisms of Action of Estrogen and SERMs to Patient and Treatment Selection in Clinical Practice Donald P. McDonnell,
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Cell Communication Chapter 9. Please note that due to differing operating systems, some animations will not appear until the presentation is viewed in.
Gene regulation results in differential gene expression, leading to cell specialization.
Determining the Effect of Triclosan on the Growth of Cancer Cells Lydia Alf and Winnifred Bryant Ph. D. Department of Biology University of Wisconsin,
Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.
AP Biology The Cell Cycle Part 1. One cell becoming two.
 Regulation of Cell Number and Cancer Cells Special Limited Edition Packet Tuesday, November 10,
Regulation of Estrogen related receptor alpha localization and signaling by the kinesin KIF17 Nilsa M. Méndez 1 and Geri E. Kreitzer 2 1 Industrial Biotechnology.
Chapter 12: The Cell Cycle
Prognostic and Predictive Factors: Current Evidence for Individualized Therapy Predictive Molecular Markers: Hormone Receptor Status Presented by Kathleen.
Biochemistry Sixth Edition Chapter 31 The Control of Gene Expression Part II: Eukaryotes (cis vs. trans) Copyright © 2007 by W. H. Freeman and Company.
Greg Brooke Molecular Oncology. Prostate Cancer - Leading Cause of Cancer- related death in men - Growth dependent on androgens - Therapy targets androgen.
LONG-TERM POTENTIATION (LTP) Introduction LTP as a candidate mechanism for the activity-dependent change in the strength of synaptic connections LTP is.
Control levels of transcription factor (TF) activity.
Cell Communication Chapter 9.
 Signaling molecules that function within an organism to control metabolic processes within cells, the growth and differentiation of tissues, the synthesis.
Lecture 12: Cancer: a cellular perspective Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular.
Natural and environmental estrogens
Overproduction of Metabolites of Industrial Microorganisms.
Estrogen receptor-α directly regulates the hypoxia inducible factor 1 pathway associated with antiestrogen response in breast cancer PNAS (49)
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Mouse Double Minute 2 (MDM2)
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
A model of the interaction of a steroid, S (eg, cortisol), and its receptor, R, and the subsequent events in a target cell. The steroid is present in the.
Med Princ Pract 2016;25(suppl 2): DOI: /
Fig. 1 Effect of l-T4 and E2 on MAPK activation and serine-118 phosphorylation of ERα in MCF-7 cells. A, MCF-7 cells were treated.
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
M.B.Ch.B, MSC, DCH (UK), MRCPCH
Chapter 12: The Cell Cycle
Cell to Cell Communication via Enzyme Linked Receptors
Figure 1 A schematic representation of the HER2 signalling pathway
Chapter 12: The Cell Cycle
Figure 2 Oestrogen receptor signalling pathways
Chapter 12: The Cell Cycle
Michèle Algarté-Génin, Olivier Cussenot, Pierre Costa  European Urology 
Selective estrogen receptor modulation
Unit III Information Essential to Life Processes
Estrogen receptor α, but not β, plays a major role in 17β-estradiol-induced murine cholesterol gallstones  Helen H. Wang, Nezam H. Afdhal, David Q.-H.
Mechanism of Hormonal Action
Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells  Daniela Stoppoloni, BSc, Luisa Salvatori, BSc, Annamaria Biroccio,
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Insulin-Like Growth Factor-1 Promotes Wound Healing in Estrogen-Deprived Mice: New Insights into Cutaneous IGF-1R/ERα Cross Talk  Elaine Emmerson, Laura.
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome  Hector L. Franco, Anusha Nagari, W. Lee Kraus 
AP Biology The Cell Cycle.
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Chapter 12: The Cell Cycle
Chapter 12: The Cell Cycle
Volume 1, Issue 3, Pages (April 2002)
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
Presentation transcript:

Functional interactions between calmodulin and estrogen receptor-α 逄雷制作

Introduction ◇ Estrogen receptor signalling ◆Genomic effects Classical Non-classical ◆Nongenomic effects Ca2+ MAPK/ERK PI3K/PKB(Akt) NO

Introduction ◇Estrogen receptor signalling

Introduction ◇ Estrogen receptor signalling The complexity of ER function is further increased by the existence of cross-talk between the nongenomic and genomic ER signalling pathways.

Introduction ◇ Ca2+/calmodulin signalling insulin receptor epidermal growth factor receptor angiotensin II receptor G protein-coupled receptors

A large body of data supports a fundamental role for calmodulin in Introduction ◇ Ca2+/calmodulin signalling A large body of data supports a fundamental role for calmodulin in cell proliferation and cell cycle pro- gression.

Calmodulin and ER ◇Interaction between calmodulin and ER Calmodulin concentrations are increased in malignant human mammary tissue (ii) Ca2+/calmodulin stimulates E2 binding to ER (iii) Calmodulin binds to ER in a Ca2+-dependent manner and this increases the Kd of E2 binding

Calmodulin and ER ◇Interaction between calmodulin and ER (iv) Ca2+/calmodulin stimulates tyrosine phosphorylation and activation of ER (v) association of calmodulin with activated estrogen-ER complex increases the interaction of the complex with ERE (vi) calmodulin is required for the formation of the ER-ERE complex and for activation of an estrogen responsive promotor

Calmodulin and ER ◇Interaction between calmodulin and ER (i) (ii) (iv) (v) (vi) ★ Ca2+/calmodulin may participate in ER-induced transcriptional activation and the mitogenic effects of estrogen.

Calmodulin and ER ◇ Interaction between calmodulin and ER E2 administration to ovariectomized mice up-regulated,independently of ER, by 4.5-fold the expression of calmodulin mRNA in the uterus.

Calmodulin and ER ◇ Interaction between calmodulin and ER ◆ Calmodulin has been shown to interact with ER both in vitro and in cells. ◆ Binding is specific for ERα, with no ass- ociation detected between calmodulin and ERβ. ◆E2 treatment has no significant effect on the interaction.

Calmodulin and ER ◇Calmodulin modulates degradation of ERα ◆ Incubation with the calmodulin antagonists dra-matically decreased the amount of ERα in MCF-7 cell lysates,with essentially no ER protein detected after 16 h incubationwith CGS9343B. ◆ Neither CGS9343B nor trifluoperazine alters the amount of ERα mRNA . ★Calmodulin stabilizes ERα by reducing its degradation.

Calmodulin and ER ◇Ca2+ and calmodulin are necessary for E2-stimulated transcriptional activity of ERα ◆ Incubation of cells with the calmodulin antagonist CGS9343B completely eliminated the ability of E2 to stimulate ERα transcriptional activation. ◆Incubating MCF-7 cells with the cell-permeable Ca2+ chelator BAPTA-AM abrogated E2-induced ERα transcriptional activation.

Putative mechanism of calmodulin in ERα function A. the interaction of ERα with calmodulin (CaM) and transcriptional coactivators. This complex activates transcription of ERα target genes.

Putative mechanism of calmodulin in ERα function B.In the absence of calmodulin the conformation of ERα is altered, facilitating its association with corepressors and blocking interaction with coactivators. Gene transcription is thus inhibited.

Putative mechanism of calmodulin in ERα function At normal intracellular calmodulin concentrations, E2 induces both transcriptional activation and degradation of ERα.

Putative mechanism of calmodulin in ERα function B. When calmodulin is over expressed, as occurs in breast carcinoma, ERα degradation is reduced. The increase in the amount of ERα results in an enhancement of the growth-promoting effects of E2.

Conclusion ◆ Calmodulin antagonists inhibit the growth of breast cell lines and augment antiestrogen therapy. ★ The molecular interaction between calmodulin and ERα could be a potential target for novel therapeutic interventions in patients with breast cancer.

The end